Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01821261
Other study ID # LAEBBA0004
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date April 30, 2014
Est. completion date July 31, 2014

Study information

Verified date January 2019
Source Johnson & Johnson Consumer and Personal Products Worldwide
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Subjects will be given special instructions about eating, smoking and taking care of their teeth during the 18 hours before they come to the dentist's office for screening. At that first visit, they will be examined by a dentist, who will examine their mouths with a dental instrument to determine whether they qualify to participate in the trial. Someone who works for the dentist will also take some oral measurements.

Participants who qualify to be in the study will receive a treatment for their gingivitis and have an equal chance of being assigned to one of three treatment groups. Subjects in all three groups will be given toothpaste that is already available in stores. They will brush their teeth twice daily with a one-inch strip of toothpaste in their regular manner. After brushing, subjects in one group will use an experimental mouth rinse that is not available in stores. Another group will be given a mouth rinse to use that is already available in stores, and the third group will not use any mouth rinse at all. After they receive their assigned products subjects will be supervised while they brush their teeth and/or rinse to ensure they understand exactly how to use the products. All other brushing and rinsing over the next three months will be at home, but subjects will be required to keep a diary to record their brushing and rinsing times twice each day.

Subjects will be required to bring their diaries and any leftover toothpaste and mouth rinse with them for four more scheduled appointments after about 1 week, 2 weeks, 4 weeks, and 3 months. At those appointments, the dentist will examine their mouths, make sure there are no safety concerns, and examine again to get the measurements needed. One of the dentist's staff members will take other measurements as well.

The study will determine the measured effects of the experimental mouth rinse on gingivitis, and compare these results to the mouth rinse that is already available, as well as to using no mouth rinse at all.


Description:

At screening/baseline, subjects will present to the clinical site having refrained from oral hygiene for at least 8 hours, but no more than 18 hours, and from eating or smoking for at least 4 hours for baseline examinations. Baseline examinations will include Macpherson modification of the Lobene Stain Index (Extrinsic Stain), Volpe-Manhold Index (Calculus), and oral hard and soft tissue exam, Modified Gingival Index (MGI), Bleeding Index (BI) and Plaque Index (PI). After the baseline oral examinations, subjects who qualify will receive a whole-mouth supragingival dental prophylaxis and random assignment to one of three treatment groups.

Subjects randomized to the control group will brush twice daily with a marketed fluoride toothpaste. Subjects randomized to the experimental group will brush twice daily with a marketed fluoride toothpaste and use an experimental mouth rinse. The last randomized group will brush twice daily with a marketed fluoride toothpaste and rinse with a marketed mouth rinse twice daily. The first product use will be conducted under supervision of study personnel. All other brushing and rinsing will be unsupervised and the subjects will be required to maintain a diary card to document twice-daily product use, with brushing and rinsing times. Diaries along with product accountability will be used to check for subject compliance.

Subjects will return to the clinical site after one week (Day 7±1 day), two weeks (Day 14±2 days), four weeks (Day 28±3 days) and three months (Day 91±5 days). Oral hard and soft tissue safety, MGI, BI, and PI will be assessed at all visits. Extrinsic Stain and Calculus will be assessed at baseline, four weeks and three months by a different examiner.

At the end of the study, subjects will return all used and unused product to the clinical site.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date July 31, 2014
Est. primary completion date April 30, 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Assessed by site personnel as able to comprehend and follow the requirements of the study in the Portuguese language, and to be available on scheduled visit dates

- After being informed of all pertinent aspects of the trial, and having all questions answered, voluntarily signed an informed consent document

- Assessed by the investigator to have gingivitis, and otherwise qualify to be a participant in the trial

Exclusion Criteria:

- Relative, partner or staff of any clinical research site personnel

- Any oral, psychiatric or medical condition (including pregnancy or nursing), laboratory abnormality, or use of experimental or other products that may (per protocol or in the opinion of the investigator) compromise the safety of the participant or the interpretation of study results

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Mouth Rinse 19668-012
20 ml of experimental mouth rinse 19668-012 for 30 seconds, twice daily
Drug:
Mouth Rinse 500347078842
10 ml of mouth rinse 500347078842 for 60 seconds, twice daily
Toothpaste 035000513007
Approximately one inch of toothpaste 035000513007, twice daily

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Johnson & Johnson Consumer Inc. (J&JCI)

Outcome

Type Measure Description Time frame Safety issue
Primary Whole-mouth Mean Bleeding Index (BI) at 3 Months Bleeding after periodontal probe will be assessed by scores on a scale of 0-2 using the Gingival Bleeding Index (BI), where 0=Absence of Bleeding after 30 Seconds and 2=Immediate Bleeding. 3 months
Secondary Whole-mouth Mean Bleeding Index (BI) Bleeding after periodontal probe will be assessed by scores on a scale of 0-2 using the Gingival Bleeding Index (BI), where 0=Absence of Bleeding after 30 Seconds and 2=Immediate Bleeding. within 4 weeks
Secondary Whole-mouth Mean Modified Gingival Index (MGI) Gingivitis will be assessed by scoring inflammation on a 0-4 scale, according to the Modified Gingival Index, where 0=Normal and 4=Severe Inflammation. within 3 months
Secondary Whole Mouth Mean Plaque Index (PI) Plaque will be assessed on a scale of 0-5 using the Turesky modification of the Quigley-Hein Plaque Index, where 0=No plaque and 5=Plaque covering 2/3 or more of surface. within 3 months
Secondary Mean Area Stain Score for Mesial Region A mean area stain score for the Mesial Region will be recorded on a scale of 0-3, where 0 = no stain present, natural tooth color and 3 = stain outside pits/grooves, over 10% of surface affected within 3 months
Secondary Mean Area Stain Score for Gingival Region A mean area stain score will be recorded for Gingival Region, on a scale of 0-3, where 0 = no stain present, natural tooth color and 3 = stain outside pits/grooves, over 10% of surface affected within 3 months
Secondary Mean Area Stain Score for Distal Region A mean area stain score will be recorded for Distal Region, on a scale of 0-3, where 0 = no stain present, natural tooth color and 3 = stain outside pits/grooves, over 10% of surface affected within 3 months
Secondary Mean Area Stain Score for Body of Tooth Mean area stain scores will be recorded for Body of Tooth, on a scale of 0-3, where 0 = no stain present, natural tooth color and 3 = stain outside pits/grooves, over 10% of surface affected within 3 months
Secondary Mean Stain Intensity Score A score for stain intensity will be recorded on a scale of 0-3, where 0 = no stain and 3 = heavy, dark stain (obvious and aesthetically unacceptable) within 3 months
Secondary Mean Tartar Height Mean tartar height will be recorded in millimeters within 3 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05568290 - Interleukin-38 Levels in Individuals With Periodontitis
Completed NCT04402996 - Meteorin-like Levels in Individuals With Periodontitis
Not yet recruiting NCT06016023 - Evaluation of Macrophage Inflammatory Protein-1α as a Periodontal Disease Biomarker
Not yet recruiting NCT05497895 - The Assessment of Clinical Efficacy of Topical Application of 5% Thymoquinone Gel for Gingivitis Patients Early Phase 1
Completed NCT02884817 - Essential Oil+ELA, Plaque and Gingivitis Phase 4
Completed NCT02552589 - Effect of Toothpaste on the Reduction of Plaque and Inflammation N/A
Completed NCT02633345 - Effects on Tablets Containing Probiotic Candidate Strains N/A
Unknown status NCT01956656 - Efficacy Of Lotus Leaves In Management Of Plaque Induced Gingivitis N/A
Completed NCT02515929 - Prospective Double-Blind Randomized Controlled Clinical Trial in the Gingivitis Prevention With OPCs Phase 4
Completed NCT02980497 - Antiplaque/Antigingivitis Efficacy of Essential Oil Mouthrinses in Six-Month Study N/A
Completed NCT02235532 - Effects of Aloe Vera Toothpaste on Periodontal Parameters N/A
Completed NCT02508987 - Obesity and Oxidative Stress in Patients With Different Periodontal Status N/A
Completed NCT01941797 - Experimental Peri-implant Mucositis in Humans N/A
Completed NCT01593540 - Clinical Examination of Metal Free Interdental Brushes Phase 4
Unknown status NCT01197105 - Evaluation Study of a Mouthwash Based on Schinus Terebinthifolius to Treat Gingivitis in Children Phase 1/Phase 2
Completed NCT01236963 - Essential Oils Mouth Rinse and Dental Floss: Efficacy on Interproximal Gingivitis and Dental Plaque Accumulation N/A
Completed NCT02102295 - Effects of Antioxidant Dentifrice on Gingivitis Phase 3
Completed NCT06140784 - A Clinical Study to Assess the Gingivitis and Plaque Effects of Various Dentifrices N/A
Completed NCT02937636 - To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population N/A
Completed NCT06212908 - Assessment of Periodontal Therapy and Biofilm Management in Breast Cancer N/A